This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Chiral Technologies Inc., a foreign-owned, for-profit manufacturer of goods. The $6,015.00 contract is for the procurement of a Chiralcel OD-H semi-preparative chromatography column, which is used for chiral separations and analysis in biomedical research. Chiral Technologies Inc. is a specialized supplier of advanced...
This is a firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Chiral Technologies Inc., a foreign-owned manufacturer of chiral separation products and services. The $56,889.50 contract is for the procurement of specialized Chiralcel OZ and Chiralpak IF preparative columns, which are used for chiral separations to support NCATS' biomedical research efforts. The award was not set...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $11,830.00 firm fixed-price purchase order contract to Chiral Technologies Inc., a foreign-owned, for-profit manufacturer of specialized chromatography products and chiral separation technologies. The contract, which does not have a set-aside designation, is for the delivery of "CHIRAL PREP LCCOLUM" to support the NIAAA's biomedical...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a firm fixed price purchase order contract to Chiral Technologies Inc., a foreign-owned for-profit manufacturer of goods, for separation services of NIAAA-generated compounds. The contract has a ceiling value of $10,059.00 and a period of performance ending on September 8, 2025. This award was made without a set-aside designation, indicating Chiral Technologies Inc. competed openly for this specialized procurement...
The federal contract award HHSN271201500037A, valued at $498,000.00, was issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Chemdiv, Inc., a for-profit organization based in San Diego, California, to provide small molecule compounds to support the National Center for Advancing Translational Sciences (NCATS) Pharmacologically Active Chemical Toolbox...
<p>The U.S. National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $452,500.00 firm fixed-price purchase order contract to Chemroutes Corporation, a foreign-owned for-profit organization, for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program. The contract has an ultimate completion date of April 30, 2016 and was awarded on December 23, 2015. This contract was not set aside for any particular business type.</p>
<p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm-fixed-price purchase order to Chemdiv, Inc. to provide 10,000 proprietary chemical compounds at 8 micromolar each. The total potential value of the award is $128,000.00. The award was not set aside for any specific business type. The contract has a completion date of September 4, 2017.</p>
This is a $115,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED, a global contract research and development organization. The contract is for the provision of chemical compounds, small molecule compound libraries, analogues, and other materials to support NIDA's research activities, which may include testing anti-cancer drug candidates, lowering...
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the U.S. Department of Health and Human Services, to EMD Millipore Corporation, a foreign-owned, for-profit manufacturer of laboratory products and services. The $353,650 firm-fixed-price purchase order is for the provision of an Amnis ImageStream Mark Flow Cytometer, a specialized piece of laboratory equipment used in biomedical research and drug development. The award is not...
The U.S. National Institute on Drug Abuse (NIDA) awarded a $24,620.00 firm fixed-price purchase order to Zaiput Flow Technologies LLC, a for-profit limited liability company that manufactures innovative separation tools for continuous flow chemistry applications in the pharmaceutical industry. The award, with a completion date of February 1, 2019, is for the acquisition of 4 membrane-based liquid-liquid/gas separators, a back pressure regulator, and related consumables. This award does not...